These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31729971)

  • 21. Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?
    Sandrasegaran K; Cui E; Elkady R; Gasparis P; Borthakur G; Tann M; Liangpunsakul S
    Eur Radiol; 2018 Oct; 28(10):4215-4224. PubMed ID: 29651764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-center preclinical study of gadoxetate DCE-MRI in rats as a biomarker of drug induced inhibition of liver transporter function.
    Karageorgis A; Lenhard SC; Yerby B; Forsgren MF; Liachenko S; Johansson E; Pilling MA; Peterson RA; Yang X; Williams DP; Ungersma SE; Morgan RE; Brouwer KLR; Jucker BM; Hockings PD
    PLoS One; 2018; 13(5):e0197213. PubMed ID: 29771932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Lv J; Xu Y; Xu L; Nie L
    Radiology; 2021 Jul; 300(1):89-97. PubMed ID: 33904773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: Preliminary results.
    Wagner M; Hectors S; Bane O; Gordic S; Kennedy P; Besa C; Schiano TD; Thung S; Fischman A; Taouli B
    J Magn Reson Imaging; 2018 Oct; 48(4):1091-1103. PubMed ID: 29638020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits.
    Liu HF; Wang Q; Du YN; Zhu ZH; Li YF; Zou LQ; Xing W
    Magn Reson Imaging; 2020 Jul; 70():57-63. PubMed ID: 32325235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative assessment of liver function with hepatocyte fraction: Comparison with T1 relaxation-based indices.
    Bi XJ; Zhang XQ; Zhang T; Xu L; Huang AN; Liu MT; Jiang JF; Chen WB
    Eur J Radiol; 2021 Aug; 141():109779. PubMed ID: 34029932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of Texture Analysis on Gadoxetic Acid-enhanced MR for Detecting Liver Fibrosis in a Rat Model.
    Xu J; Wang X; Jin ZY; You Y; Wang Q; Wang ST; Xue HD
    Chin Med Sci J; 2019 Mar; 34(1):24-32. PubMed ID: 30961777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.
    Chen BB; Hsu CY; Yu CW; Wei SY; Kao JH; Lee HS; Shih TT
    Eur Radiol; 2012 Jan; 22(1):171-80. PubMed ID: 21879400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver.
    Lagadec M; Doblas S; Giraudeau C; Ronot M; Lambert SA; Fasseu M; Paradis V; Moreau R; Pastor CM; Vilgrain V; Daire JL; Van Beers BE
    Radiology; 2015 Feb; 274(2):379-86. PubMed ID: 25289480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis.
    Choi YR; Lee JM; Yoon JH; Han JK; Choi BI
    Invest Radiol; 2013 Aug; 48(8):607-13. PubMed ID: 23538889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
    Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
    Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test.
    Kim DK; Choi JI; Choi MH; Park MY; Lee YJ; Rha SE; Jung SE
    AJR Am J Roentgenol; 2018 Sep; 211(3):580-587. PubMed ID: 29995498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
    Ma C; Liu A; Wang Y; Geng X; Hao L; Song Q; Sun B; Wang H; Zhao G
    Life Sci; 2014 Jul; 108(2):104-8. PubMed ID: 24881519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model.
    Zhou L; Chen TW; Zhang XM; Yang Z; Tang HJ; Deng D; Zeng NL; Wang LY; Chen XL; Li H; Li CP; Li L; Xie XY; Hu J
    J Magn Reson Imaging; 2014 Apr; 39(4):872-8. PubMed ID: 24123400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
    Wu T; Tang DR; Wang F; Xia S; Sun FY
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
    [No Abstract]   [Full Text] [Related]  

  • 38. Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio.
    Yoon JH; Lee JM; Kang HJ; Ahn SJ; Yang H; Kim E; Okuaki T; Han JK
    Radiology; 2019 Jan; 290(1):125-133. PubMed ID: 30375932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging.
    Yang D; Li D; Li J; Yang Z; Wang Z
    Eur J Radiol; 2020 Apr; 125():108857. PubMed ID: 32113153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.